Early this year, Fever-Tree announced a deal with Molson Coors (TAP) that established a 50/50 partnership for Fever-Tree’s US business. Molson will take over all supply chain, logistics and ...
The deal gives Molson Coors exclusive commercialization rights to Fever-Tree’s U.S. portfolio, alongside an equity investment by Molson Coors into Fevertree Drinks plc Partnership designed to fuel ...
Add Yahoo as a preferred source to see more of our stories on Google. Fever-Tree's tonic waters stood out among the rest, not only because it is considered a high-quality brand, but because it offers ...
Molson Coors has evolved into a global beverage giant, expanding beyond beer with strategic acquisitions and partnerships. The 2025 Fever-Tree deal strengthens TAP's 'Beyond Beer' strategy and ...
The analysts added that Molson Coors’ 8.5% equity stake aligns incentives and that U.S. profitability is expected to rise as production shifts onshore. Molson Coors has guaranteed an absolute level of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results